Astrana Health, Inc. (NASDAQ:ASTH) Receives $53.29 Consensus Target Price from Brokerages

Key Points

• Astrana Health, Inc. (NASDAQ:ASTH) has received a consensus recommendation of "Moderate Buy" from ten brokerages, with six buy ratings, three holds, and one sell rating.
• Zacks Research notably downgraded Astrana Health from a "strong-buy" to a "strong sell" rating, indicating a shift in analyst sentiment.
• The company's recent earnings report revealed a miss on expected earnings per share, reporting $0.19 compared to the consensus estimate of $0.36.

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) have been given an average rating of "Moderate Buy" by the ten brokerages that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $53.2857.

Separately, Zacks Research lowered shares of Astrana Health from a "strong-buy" rating to a "strong sell" rating in a research report on Monday, September 1st.

Astrana Health Stock Performance

NASDAQ ASTH traded down $1.12 during trading hours on Wednesday, hitting $29.70. 359,392 shares of the company's stock traded hands, compared to its average volume of 452,868. The business's fifty day moving average price is $26.48 and its two-hundred day moving average price is $28.13. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $1.66 billion, a P/E ratio of 58.24, a P/E/G ratio of 0.74 and a beta of 0.85. Astrana Health has a 52 week low of $21.20 and a 52 week high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.17). The business had revenue of $654.81 million for the quarter, compared to the consensus estimate of $639.13 million. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The business's quarterly revenue was up 34.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.40 earnings per share. Astrana Health has set its Q3 2025 guidance at EPS. Equities research analysts predict that Astrana Health will post 1.15 EPS for the current year.

Hedge Funds Weigh In On Astrana Health

Hedge funds have recently modified their holdings of the company. Covestor Ltd boosted its position in shares of Astrana Health by 777.6% in the first quarter. Covestor Ltd now owns 2,001 shares of the company's stock worth $62,000 after purchasing an additional 1,773 shares during the period. Tower Research Capital LLC TRC boosted its position in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company's stock worth $115,000 after purchasing an additional 3,517 shares during the period. AlphaQuest LLC boosted its position in shares of Astrana Health by 144.2% in the first quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock worth $151,000 after purchasing an additional 2,883 shares during the period. State of Wyoming bought a new position in shares of Astrana Health in the second quarter worth approximately $132,000. Finally, US Bancorp DE boosted its position in shares of Astrana Health by 21.3% in the first quarter. US Bancorp DE now owns 5,791 shares of the company's stock worth $180,000 after purchasing an additional 1,015 shares during the period. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.